Mendus AB (publ) (IMMU.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -18.41%; 2025 (actual)
ROA: -17.1%; 2025 (actual)
Gross Margin: -
Net Margin: -
Total Assets: SEK 628.32M; 2025 (actual)
Net Income: -SEK 113.26M; 2025 (actual)
Valuation: SEK 355.51M; 2025 (actual)
Stock Price: SEK 5.60; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-18.41%	-21.11%	-26.66%	-36.5%	-57.49%	-135.23%
ROA	-17.1%	-18.75%	-19.75%	-19.83%	-19.83%	-19.83%
Total Assets	SEK 628.32M	SEK 563.66M	SEK 563.66M	SEK 563.66M	SEK 563.66M	SEK 563.66M
Sector average	SEK 2,857.19M	SEK 2,900.24M	SEK 3,045.01M	SEK 3,280.29M	SEK 3,536.41M	SEK 3,762.91M
Net Income	-SEK 113.26M	-SEK 111.73M	-SEK 111.34M	-SEK 111.75M

Amounts in SEK (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Mendus AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Valuation	SEK 355.51M	SEK 350.72M	SEK 349.47M	SEK 350.76M	SEK 350.76M	SEK 350.77M
Sector average	SEK 3,960.50M	SEK 5,151.30M	SEK 5,189.24M	SEK 5,317.34M	SEK 5,514.33M	SEK 5,636.78M

Stock Price	SEK 5.60	SEK 5.52	SEK 5.50	SEK 5.53	SEK 5.53	SEK 5.53
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41